BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7634398)

  • 21. 4,5-Dianilinophthalimide: a protein-tyrosine kinase inhibitor with selectivity for the epidermal growth factor receptor signal transduction pathway and potent in vivo antitumor activity.
    Buchdunger E; Trinks U; Mett H; Regenass U; Müller M; Meyer T; McGlynn E; Pinna LA; Traxler P; Lydon NB
    Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2334-8. PubMed ID: 8134396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidermal growth factor (EGF) promotes phosphorylation at threonine-654 of the EGF receptor: possible role of protein kinase C in homologous regulation of the EGF receptor.
    Whiteley B; Glaser L
    J Cell Biol; 1986 Oct; 103(4):1355-62. PubMed ID: 3021781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-affinity epidermal growth factor binding is specifically reduced by a monoclonal antibody, and appears necessary for early responses.
    Bellot F; Moolenaar W; Kris R; Mirakhur B; Verlaan I; Ullrich A; Schlessinger J; Felder S
    J Cell Biol; 1990 Feb; 110(2):491-502. PubMed ID: 2298813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. alpha-Interferon potentiates epidermal growth factor receptor-mediated effects on human epidermoid carcinoma KB cells.
    Caraglia M; Leardi A; Corradino S; Ciardiello F; Budillon A; Guarrasi R; Bianco AR; Tagliaferri P
    Int J Cancer; 1995 May; 61(3):342-7. PubMed ID: 7729946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of glycosyl-phosphatidylinositol hydrolysis as a mitogenic signal for epidermal growth factor.
    Clemente R; Jones DR; Ochoa P; Romero G; Mato JM; Varela-Nieto I
    Cell Signal; 1995 May; 7(4):411-21. PubMed ID: 8527310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arginine vasopressin stimulates mesangial cell proliferation by activating the epidermal growth factor receptor.
    Ghosh PM; Mikhailova M; Bedolla R; Kreisberg JI
    Am J Physiol Renal Physiol; 2001 Jun; 280(6):F972-9. PubMed ID: 11352836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidermal growth factor stimulates tyrosine phosphorylation in the neonatal mouse: association of a M(r) 55,000 substrate with the receptor.
    Donaldson RW; Cohen S
    Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8477-81. PubMed ID: 1382290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
    Tyagi A; Agarwal R; Agarwal C
    Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor.
    Reddy KB; Mangold GL; Tandon AK; Yoneda T; Mundy GR; Zilberstein A; Osborne CK
    Cancer Res; 1992 Jul; 52(13):3636-41. PubMed ID: 1617636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Curcumin attenuates hyperglycemia-driven EGF-induced invasive and migratory abilities of pancreatic cancer via suppression of the ERK and AKT pathways.
    Li W; Wang Z; Xiao X; Han L; Wu Z; Ma Q; Cao L
    Oncol Rep; 2019 Jan; 41(1):650-658. PubMed ID: 30542713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Curcumin on Epidermal Growth Factor in Proliferative Vitreoretinopathy.
    Ren YX; Ma JX; Zhao F; An JB; Geng YX; Liu LY
    Cell Physiol Biochem; 2018; 47(5):2136-2146. PubMed ID: 29975931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidermal growth factor induced tyrosine phosphorylation of nuclear proteins associated with translocation of epidermal growth factor receptor into the nucleus.
    Holt SJ; Alexander P; Inman CB; Davies DE
    Biochem Pharmacol; 1994 Jan; 47(1):117-26. PubMed ID: 7508718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidermal growth factor (EGF) receptor T669 peptide kinase from 3T3-L1 cells is an EGF-stimulated "MAP" kinase.
    Takishima K; Griswold-Prenner I; Ingebritsen T; Rosner MR
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2520-4. PubMed ID: 1848706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potent SHC tyrosine phosphorylation by epidermal growth factor at low receptor density or in the absence of receptor autophosphorylation sites.
    Soler C; Alvarez CV; Beguinot L; Carpenter G
    Oncogene; 1994 Aug; 9(8):2207-15. PubMed ID: 8036006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein-tyrosine-phosphatase-mediated epidermal growth factor (EGF) receptor transinactivation and EGF receptor-independent stimulation of mitogen-activated protein kinase by bradykinin in A431 cells.
    Graness A; Hanke S; Boehmer FD; Presek P; Liebmann C
    Biochem J; 2000 Apr; 347(Pt 2):441-7. PubMed ID: 10749673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Annexin I is phosphorylated in the multivesicular body during the processing of the epidermal growth factor receptor.
    Futter CE; Felder S; Schlessinger J; Ullrich A; Hopkins CR
    J Cell Biol; 1993 Jan; 120(1):77-83. PubMed ID: 8093248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early events elicited by bombesin and structurally related peptides in quiescent Swiss 3T3 cells. I. Activation of protein kinase C and inhibition of epidermal growth factor binding.
    Zachary I; Sinnett-Smith JW; Rozengurt E
    J Cell Biol; 1986 Jun; 102(6):2211-22. PubMed ID: 3011811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with in vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785).
    Discafani CM; Carroll ML; Floyd MB; Hollander IJ; Husain Z; Johnson BD; Kitchen D; May MK; Malo MS; Minnick AA; Nilakantan R; Shen R; Wang YF; Wissner A; Greenberger LM
    Biochem Pharmacol; 1999 Apr; 57(8):917-25. PubMed ID: 10086326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exogenous phosphotyrosine modulates epidermal growth factor receptor tyrosine phosphorylation.
    Mishra S; Hamburger AW
    Carcinogenesis; 1993 Feb; 14(2):269-73. PubMed ID: 7679612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation.
    Lipson KE; Pang L; Huber LJ; Chen H; Tsai JM; Hirth P; Gazit A; Levitzki A; McMahon G
    J Pharmacol Exp Ther; 1998 May; 285(2):844-52. PubMed ID: 9580635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.